← Leaderboards
Virginia G. Johnson
Emergent Product Development Gaithersbur
$3,290,712
Attributed
$3,290,712
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.8M · FY2011–21$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$3,290,712 · 1
By mechanism
N01$3,290,712 · 1
Top collaborators
No co-investigators on record.
Most similar at Emergent Product Development Gaithersbur
Same institution · by research overlap
- Laurence Lemiale$61,222,506
- Sukjoon Park$31,572,885
- Ajoy Chakrabarti$1,624,359
- Robert Jay Hopkins$335,310
- Hopkins Robert$2,678,071
Others in their field
Top investigators on “Therapeutic Monoclonal Antibodies”
- Bambra Strokes · Ppd Development Lp$461,655,950
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$217,417,933
- Lawrence Corey · Fred Hutchinson Cancer Center$212,381,140
- Randall J Bateman · Washington University$74,454,335
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$69,994,218
- Milan Tomic · Xoma Corporation$64,944,259
Research focus
Therapeutic Monoclonal AntibodiesAnimalsAnthrax DiseaseAreaBacillus AnthracisSupport ContractsTherapeutic DevelopmentAdvanced DevelopmentContractsFallsClinical DevelopmentPre-ClinicalPreclinical Development